Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase

被引:154
|
作者
Forouhar, Farhad
Anderson, J. L. Ross
Mowat, Christopher G.
Vorobiev, Sergey M.
Hussain, Arif
Abashidze, Mariam
Bruckmann, Chiara
Thackray, Sarah J.
Seetharaman, Jayaraman
Tucker, Todd
Xiao, Rong
Ma, Li-Chung
Zhao, Li
Acton, Thomas B.
Montelione, Gaetano T.
Chapman, Stephen K.
Tong, Liang [1 ]
机构
[1] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA
[2] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland
[3] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
[4] Rutgers State Univ, NE Struct Genom Consortium, Piscataway, NJ 08854 USA
关键词
cancer; heme enzymes; immunomodulation; indoleamine 2,3-dioxygenase;
D O I
10.1073/pnas.0610007104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO) constitute an important, yet relatively poorly understood, family of heme-containing enzymes. Here, we report extensive structural and biochemical studies of the Xanthomonas campestris TOO and a related protein SO4414 from Shewanella oneidensis, including the structure at 1.6-angstrom resolution of the catalytically active, ferrous form of TOO in a binary complex with the substrate L-Trp. The carboxylate and ammonium moieties of tryptophan are recognized by electrostatic and hydrogen-bonding interactions with the enzyme and a propionate group of the heme, thus defining the L-stereospecificity. A second, possibly allosteric, L-Trp-binding site is present at the tetramer interface. The sixth coordination site of the heme-iron is vacant, providing a dioxygen-binding site that would also involve interactions with the ammonium moiety Of L-Trp and the amide nitrogen of a glycine residue. The indole ring is positioned correctly for oxygenation at the C2 and C3 atoms. The active site is fully formed only in the binary complex, and biochemical experiments confirm this induced-fit behavior of the enzyme. The active site is completely devoid of water during catalysis, which is supported by our electrochemical studies showing significant stabilization of the enzyme upon substrate binding.
引用
收藏
页码:473 / 478
页数:6
相关论文
共 50 条
  • [21] Indoleamine 2,3-dioxygenase gene expression and kynurenine to tryptophan ratio correlation with nasopharyngeal carcinoma progression and survival
    Souissi, Sameh
    Ghedira, Randa
    Macherki, Yosra
    Ben-Haj-Ayed, Ahlem
    Gabbouj, Sallouha
    Remadi, Yasmine
    Sfar, Imen
    Chadli, Zohra
    Aouam, Karim
    Hassine, Mohsen
    Bouaouina, Noureddine
    Zakhama, Abdelfattah
    Hassen, Elham
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (09)
  • [22] Determination of kynurnine and tryptophan, biomarkers of indoleamine 2,3-dioxygenase by LC-MS/MS in plasma and tumor
    Wang, Wenyan
    Zhuang, Xuhui
    Liu, Wenrong
    Dong, Lina
    Sun, Heyuan
    Du, Guangying
    Ye, Liang
    BIOANALYSIS, 2018, 10 (16) : 1335 - 1344
  • [23] Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma
    Mohapatra, Soumya R.
    Sadik, Ahmed
    Tykocinski, Lars-Oliver
    Dietze, Jorn
    Poschet, Gernot
    Heiland, Ines
    Opitz, Christiane A.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [24] Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia
    Sobash, Philip T.
    Kolhe, Ravindra
    Karim, Nagla Abdel
    Guddati, Achuta K.
    Jillella, Anand
    Kota, Vamsi
    FUTURE ONCOLOGY, 2020, 16 (36) : 3085 - 3094
  • [25] Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma
    de Jong, Renske A.
    Kema, Ido P.
    Boerma, Annemarie
    Boezen, H. Marike
    van der Want, Johannes J. L.
    Gooden, Marloes J. M.
    Hollema, Harry
    Nijman, Hans W.
    GYNECOLOGIC ONCOLOGY, 2012, 126 (03) : 474 - 480
  • [26] The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
    Brochez, Lieve
    Chevolet, Ines
    Kruse, Vibeke
    EUROPEAN JOURNAL OF CANCER, 2017, 76 : 167 - 182
  • [27] Novel candesartan derivatives as indoleamine 2,3-dioxygenase inhibitors
    Matsuno, Kenji
    Yamazaki, Hiroshi
    Isaka, Yoshinobu
    Takai, Kazushige
    Unno, Yuka
    Ogo, Naohisa
    Ishikawa, Yoshinobu
    Fujii, Satoshi
    Takikawa, Osamu
    Asai, Akira
    MEDCHEMCOMM, 2012, 3 (04) : 475 - 479
  • [28] Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance
    Hoffmann, Delia
    Dvorakova, Tereza
    Schramme, Florence
    Stroobant, Vincent
    Van den Eynde, Benoit J.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [29] The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
    Suvieri, Chiara
    Belladonna, Maria Laura
    Volpi, Claudia
    CELLS, 2024, 13 (22)
  • [30] Systemic Changes of Tryptophan Catabolites via the Indoleamine-2,3-dioxygenase Pathway in Primary Cervical Cancer
    Fotopoulou, Christina
    Sehouli, Jalid
    Pschowski, Rene
    Von Haehling, Stephan
    Domanska, Grazyna
    Braicu, Elena-Ioana
    Fusch, Gerhard
    Reinke, Petra
    Schefold, Joerg C.
    ANTICANCER RESEARCH, 2011, 31 (08) : 2629 - 2635